Topics

"Acer Therapeutics Announces Acceptance Priority Review EDSIVO Treatment" Drugs and Medication Database: Page 2

05:23 EST 29th February 2020 | BioPortfolio

Here are the most relevant "Acer Therapeutics Announces Acceptance Priority Review EDSIVO Treatment" Drugs and Medications that we have found in our database.

More Information about "Acer Therapeutics Announces Acceptance Priority Review EDSIVO Treatment" on BioPortfolio

We have published hundreds of Acer Therapeutics Announces Acceptance Priority Review EDSIVO Treatment news stories on BioPortfolio along with dozens of Acer Therapeutics Announces Acceptance Priority Review EDSIVO Treatment Clinical Trials and PubMed Articles about Acer Therapeutics Announces Acceptance Priority Review EDSIVO Treatment for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Acer Therapeutics Announces Acceptance Priority Review EDSIVO Treatment Companies in our database. You can also find out about relevant Acer Therapeutics Announces Acceptance Priority Review EDSIVO Treatment Drugs and Medications on this site too.

Showing "Acer Therapeutics Announces Acceptance Priority Review EDSIVO Treatment" Drugs and Medications 26–36 of 36

Possibly Relevant

Xuriden [wellstat therapeutics corporation]

These highlights do not include all the information needed to use XURIDEN safely and effectively. See full prescribing information for XURIDEN. XURIDEN (uridine triacetate) oral granules Initial U.S. Approval: 2015

Baxdela [melinta therapeutics, inc]

These highlights do not include all the information needed to use BAXDELA safely and effectively. See full prescribing information for BAXDELA. BAXDELA (delafloxacin) tablets, for oral use BAXDELA (delafloxacin) for injection, for intravenous use Initial

Mitosol [mobius therapeutics llc]

These highlights do not include all the information needed to use Mitosol safely and effectively. See full prescribing information for Mitosol. Mitosol (mitomycin for solution) for ophthalmic useInitial U.S. Approval: 1974

Prevident fresh mint [colgate oral pharmaceuticals, inc.]

Colgate PreviDent Gel

Sf 5000 plus [cypress pharmaceutical, inc.]

SF 5000 Plus 1.1% Sodium Fluoride - Prescription Dental Cream

Sf [cypress pharmaceutical, inc.]

SF 1.1% Gel 1.1% Sodium Fluoride - Brush-On Gel

Sodium fluoride [method pharmaceuticals, llc]

Sodium Fluoride Drops

Qutenza [acorda therapeutics, inc.]

These highlights do not include all the information needed to use QUTENZA safely and effectively. See full prescribing information for QUTENZA. QUTENZA (capsaicin) 8% patch Initial U.S. Approval: 2009

Epinephrine [a-s medication solutions]

These highlights do not include all the information needed to use EPINEPHRINE INJECTION, USP AUTO-INJECTOR safely and effectively. See full prescribing information for EPINEPHRINE INJECTION, USP AUTO-INJECTOR. Epinephrine injection, USP auto-injector 0.3

Epinephrine [preferred pharmaceuticals inc.]

These highlights do not include all the information needed to use EPINEPHRINE INJECTION, USP AUTO-INJECTOR safely and effectively. See full prescribing information for EPINEPHRINE INJECTION, USP AUTO-INJECTOR. Epinephrine injection, USP auto-injector 0.3

Oxygen [aspen air us corp]

OXYGEN - 001



Quick Search